Your browser doesn't support javascript.
loading
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Flaten, Vanessa; Laurent, Cyril; Coelho, Joana E; Sandau, Ursula; Batalha, Vânia L; Burnouf, Sylvie; Hamdane, Malika; Humez, Sandrine; Boison, Detlev; Lopes, Luísa V; Buée, Luc; Blum, David.
Affiliation
  • Coelho JE; ‡Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa, Lisbon, Portugal.
  • Sandau U; §Legacy Research Institute, Portland, OR 97232, U.S.A.
  • Batalha VL; ‡Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa, Lisbon, Portugal.
  • Boison D; §Legacy Research Institute, Portland, OR 97232, U.S.A.
  • Lopes LV; ‡Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa, Lisbon, Portugal.
Biochem Soc Trans ; 42(2): 587-92, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24646282
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeine / Purinergic P1 Receptor Antagonists / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Animals / Humans Language: En Journal: Biochem Soc Trans Year: 2014 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeine / Purinergic P1 Receptor Antagonists / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Animals / Humans Language: En Journal: Biochem Soc Trans Year: 2014 Document type: Article